Maqsood Siddiqi
Overview
Explore the profile of Maqsood Siddiqi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bose S, Mandal R, Banerjee D, Vernekar M, Siddiqi M, Chakrabarti J, et al.
Cancer Epidemiol
. 2025 Feb;
95:102776.
PMID: 39970849
Background: Cervical cancer remains a leading cause of cancer related morbidity and mortality among women worldwide, particularly in low-and middle- income countries (LMICs). The incidence of cervical cancer has declined...
2.
Biswas S, Chenkual S, Bhattacharjee K, Lalchhandama C, Ghosh A, Siddiqi M
Asian Pac J Cancer Prev
. 2025 Jan;
26(1):347-358.
PMID: 39874018
Objective: The case-control study aims to identify the potential risk and protective factors contributing to breast cancer risk in the high-incidence Aizawl population and the low-incidence Agartala population, using age-specific...
3.
Malvi S, Esmy P, Muwonge R, Joshi S, Poli U, Lucas E, et al.
J Natl Cancer Inst Monogr
. 2024 Nov;
2024(67):317-328.
PMID: 39529521
Background: While recommending a human papillomavirus (HPV) single-dose vaccination schedule in 2022, the World Health Organization highlighted the need for long-term follow-up studies to monitor waning of protection. We report...
4.
Bhatla N, Muwonge R, Malvi S, Joshi S, Poli U, Lucas E, et al.
Hum Vaccin Immunother
. 2023 Dec;
19(3):2289242.
PMID: 38078840
Long-term follow-up of a cohort of unmarried girls who received one, two, or three doses of quadrivalent HPV vaccine, between 10 and 18 years of age, in an Indian multi-centric...
5.
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, et al.
Vaccine
. 2022 Nov;
41(1):236-245.
PMID: 36446654
Background: The recent World Health Organization recommendation supporting single-dose of HPV vaccine will significantly reduce programmatic cost, mitigate the supply shortage, and simplify logistics, thus allowing more low- and middle-income...
6.
Basu P, Malvi S, Joshi S, Bhatla N, Muwonge R, Lucas E, et al.
Lancet Oncol
. 2021 Oct;
22(11):1518-1529.
PMID: 34634254
Background: A randomised trial designed to compare three and two doses of quadrivalent human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort study after suspension...
7.
Biswas S, Syiemlieh J, Nongrum R, Sharma S, Siddiqi M
Asian Pac J Cancer Prev
. 2021 Sep;
22(9):2923-2928.
PMID: 34582663
Background: Several national-level surveys have recognized a high prevalence of tobacco use in North-eastern (NE) India. However, information on tobacco use in specific population subgroups still lacks from the region....
8.
Muwonge R, Basu P, Gheit T, Anantharaman D, Verma Y, Bhatla N, et al.
PLoS One
. 2020 Dec;
15(12):e0244242.
PMID: 33373380
In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated...
9.
Biswas S, Syiemlieh J, Nongrum R, Sharma S, Siddiqi M
Asian Pac J Cancer Prev
. 2020 Dec;
21(12):3639-3646.
PMID: 33369463
Background: Breast cancer (BC) is the most common cancer among women in India and shows an increasing trend. The mammography screening seems unfeasible as a public health service in India....
10.
Basu P, Muwonge R, Bhatla N, Nene B, Joshi S, Esmy P, et al.
Papillomavirus Res
. 2019 Feb;
7:75-81.
PMID: 30711698
Earlier publication from the ongoing multi-centric study of the International Agency for Research on Cancer to evaluate less than three doses of the quadrivalent Human Papillomavirus (HPV) vaccine in India...